American Journal of Cardiovascular Drugs

, Volume 17, Issue 6, pp 493–495 | Cite as

Comment on: “Coxibs Refocus Attention on the Cardiovascular Risks of Non-Aspirin NSAIDs”

  • Martin A. Urtasun
  • Guillermo R. Prozzi
  • Gustavo H. Marín
  • Hector O. Buschiazzo
  • Martín Cañás
  • Cristian M. Dorati
  • Perla Mordujovich
Letter to the Editor

Notes

Compliance with Ethical Standards

Funding

No sources of funding were used to assist with the preparation of this manuscript.

Conflict of interest

Drs. Urtasun, Prozzi, Marín, Buschiazzo, Cañás, Dorati, and Mordujovich have no potential conflicts of interest that might be relevant to the content of this letter.

References

  1. 1.
    Thomas D, Ali Z, Zachariah S, et al. Coxibs refocus attention on the cardiovascular risks of non-aspirin NSAIDs. Am J Cardiovasc Drugs (Epub 28 Mar 2017). doi: 10.1007/s40256-017-0223-6
  2. 2.
    Nissen SE, Yeomans ND, Solomon DH, et al. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N Engl J Med. 2016;375(26):2519–29.CrossRefPubMedGoogle Scholar
  3. 3.
    Protocol for: Nissen SE, Yeomans ND, Solomon DH, et al. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N Engl J Med. 2016;375(26):2519–29. doi: 10.1056/NEJMoa1611593
  4. 4.
    Supplement to: Nissen SE, Yeomans ND, Solomon DH, et al. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N Engl J Med. 2016;375(26):2519–29. doi: 10.1056/NEJMoa1611593
  5. 5.
    Coxib and traditional NSAID Trialists’ (CNT) Collaboration, Bhala N, Emberson J, Merhi A, et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013;382(9894):769–79.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  1. 1.Centro Universitario de Farmacología, Facultad de Ciencias MédicasUniversidad Nacional de La Plata, WHO/PAHO Collaborating Centre on the Rational Use of MedicinesLa PlataArgentina
  2. 2.Federación Médica de la Provincia de Buenos Aires (FEMEBA)La PlataArgentina

Personalised recommendations